Loading clinical trials...
Loading clinical trials...
The use of an ultrathin bronchoscope (UB) has recently been introduced in the diagnosis of peripheral lung lesions. The use of the UB can be supported by navigation systems such as fluoroscopy, ultrasound guidance, electromagnetic navigation, or other technologies, which have complementary potential. Further navigation techniques are still under study. The use of ultrathin instrumentation has already been shown to significantly reduce procedural times compared to traditional instrumentation. The purpose of the study is to prospectively evaluate the institutional experience of different third-level hospital centers with the use of a UB (MP190F; Olympus Medical Systems, Tokyo, Japan) for sampling peripheral lung lesions by means of transbronchial needle aspiration (TBNA) or transbronchial biopsy (TBB), performed after fluoroscopic navigation and simultaneous radial probe-endobronchial ultrasound (RP-EBUS) assessment. Design: multicentric, observational study.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Pneumologia, Azienda Ospedaliero-Universitaria Ospedali Riuniti
Ancona, Italy
Pneumologia, Arcispedale S. Maria Nuova
Reggio Emilia, Italy
Pneumologia, ASUFC, Az. Osp. Santa Maria della Misericordia
Udine, Italy
Start Date
July 14, 2022
Primary Completion Date
July 31, 2025
Completion Date
December 31, 2025
Last Updated
February 2, 2024
148
ESTIMATED participants
Ultrathin bronchoscopy (MP190F; Olympus Medical Systems, Tokyo, Japan)
DEVICE
Lead Sponsor
Azienda Sanitaria-Universitaria Integrata di Udine
NCT07336732
NCT07190248
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05692635